| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |